Public interest in approaches that might provide prescription drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. In the current debate, some argue that the governments financial, scientific, and/or clinical support of health-related research and development (R&D) entitles the public to commensurate considerations in the prices charged for any resulting drugs. Others view government intervention in price decisions based upon initial federal funding as contrary to a long-term trend of government promotion of innovation, technological advancement, and the commercialization of technology by the business community leading to new products and processes for the marketplace.
Product Identifiers
Publisher
Creative Media Partners, LLC
ISBN-10
1288670133
ISBN-13
9781288670130
eBay Product ID (ePID)
164760593
Product Key Features
Book Title
Federal R and d, Drug Discovery, and Pricing : Insights from the Nih-University-Industry Relationship